For example, Bertotti et al. used 6 mice per PDX per arm in a two-arm MCT with 85 colorectal cancer PDXs to identify HER2 as a therapeutic target in Cetuximab-resistant colorectal cancers [11]. This evidence concerns the gene ERBB2 and colorectal cancer.